BioCentury | Jan 9, 2012
Company News

Pharmatest, ValiRx deal

...ValiRx's ValiFinn Oy subsidiary acquired Pharmatest's biomarkers business unit, along with five families of patents and...
...biomarkers business unit, along with five families of patents and patent applications and related IP. Pharmatest...
...million) based on ValiRx's close of 52p on Jan. 4, before the deal was announced. Pharmatest...
Items per page:
1 - 1 of 1
BioCentury | Jan 9, 2012
Company News

Pharmatest, ValiRx deal

...ValiRx's ValiFinn Oy subsidiary acquired Pharmatest's biomarkers business unit, along with five families of patents and...
...biomarkers business unit, along with five families of patents and patent applications and related IP. Pharmatest...
...million) based on ValiRx's close of 52p on Jan. 4, before the deal was announced. Pharmatest...
Items per page:
1 - 1 of 1